Toikumo, Sylvanus http://orcid.org/0000-0002-6024-0693
Jennings, Mariela V.
Pham, Benjamin K. http://orcid.org/0009-0005-5994-3593
Lee, Hyunjoon
Mallard, Travis T. http://orcid.org/0000-0002-3265-3001
Bianchi, Sevim B.
Meredith, John J. http://orcid.org/0000-0001-6622-6414
Vilar-Ribó, Laura http://orcid.org/0000-0001-8758-523X
Xu, Heng
Hatoum, Alexander S.
Johnson, Emma C. http://orcid.org/0000-0003-0394-777X
Pazdernik, Vanessa K. http://orcid.org/0000-0001-7566-7334
Jinwala, Zeal http://orcid.org/0009-0005-5062-0827
Pakala, Shreya R.
Leger, Brittany S.
Niarchou, Maria http://orcid.org/0000-0002-8855-7393
Ehinmowo, Michael
Jenkins, Greg D.
Batzler, Anthony
Pendegraft, Richard
Palmer, Abraham A. http://orcid.org/0000-0003-3634-0747
Zhou, Hang http://orcid.org/0000-0002-7694-6391
Biernacka, Joanna M. http://orcid.org/0000-0001-9350-4440
Coombes, Brandon J.
Gelernter, Joel http://orcid.org/0000-0002-4067-1859
Xu, Ke
Hancock, Dana B. http://orcid.org/0000-0003-2240-3604
Cox, Nancy J.
Smoller, Jordan W. http://orcid.org/0000-0002-0381-6334
Davis, Lea K. http://orcid.org/0000-0001-5143-2282
Justice, Amy C. http://orcid.org/0000-0003-0139-5502
Kranzler, Henry R. http://orcid.org/0000-0002-1018-0450
Kember, Rachel L. http://orcid.org/0000-0001-8820-2659
Sanchez-Roige, Sandra http://orcid.org/0000-0001-6137-5699
,
,
,
Funding for this research was provided by:
Tobacco-Related Disease Research Program (T32IR5226, T32IR5226, T29KT0526, T32IR5226)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (DP1DA054394, P50DA037844, DP1DA054394, K01DA051759, 5R01DA054869, R01 DA042090)
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (T32HG010464)
U.S. Department of Health & Human Services | NIH | National Institute on Alcohol Abuse and Alcoholism (AA030083, K01 AA028292)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01 MH113362)
Veterans Integrated Service Network 4 Mental Illness Research, Education and Clinical Center
Article History
Received: 24 March 2023
Accepted: 21 February 2024
First Online: 17 April 2024
Competing interests
: J.W.S. is a member of the Scientific Advisory Board of Sensorium Therapeutics (with equity) and has received grant support from Biogen. He is Principal Investigator of a collaborative study of the genetics of depression and bipolar disorder sponsored by 23andMe for which 23andMe provides analysis time as in-kind support but no payments. H.R.K. is a member of advisory boards for Clearmind Medicine, Dicerna Pharmaceuticals, Sophrosyne Pharmaceuticals and Enthion Pharmaceuticals; a consultant to Sobrera Pharmaceuticals; the recipient of research funding and medication supplies for an investigator-initiated study from Alkermes; a member of the American Society of Clinical Psychopharmacology’s Alcohol Clinical Trials Initiative, which was supported in the last 3 years by Alkermes, Dicerna, Ethypharm, Lundbeck, Mitsubishi, Otsuka and Pear Therapeutics; and, with J.G., is a holder of US patent 10,900,082 titled: ‘Genotype-guided dosing of opioid agonists’ issued 26 January 2021. The other authors declare no competing interests.